GlassScriptPhysician profile
Wendy A Kindrick
NPI 1568445054
$5,193.80
in general payments reported to CMS, 2019-2025
33 companies · $575 in 2025
The $575 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $192 · 2021: $279 · 2022: $493 · 2023: $878 · 2024: $2,379 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,206 · Consulting Fee: $1,200 · Education: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,206.22 |
| Consulting Fee | $1,200.00 |
| Education | $425.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,241.04 | 2024-2025 | |
| Abbvie INC. | $591.91 | 2019-2023 | |
| Intuitive Surgical, INC. | $504.15 | 2023-2024 | Da Vinci Surgical System |
| Pfizer INC. | $357.38 | 2019-2025 | |
| Astellas Pharma US INC | $310.41 | 2023-2025 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $239.20 | 2023-2025 | Accrufer |
| Exeltis, USA INC. | $190.17 | 2019-2025 | Slynd |
| Organon LLC | $166.47 | 2022-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $153.74 | 2023-2025 | Myfembree |
| Millicent US INC | $143.40 | 2024-2025 | Intrarosa, Femlyv |
| Hologic Sales and Service, LLC | $132.99 | 2019-2024 | Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $126.30 | 2022-2025 | |
| Glaxosmithkline, LLC. | $124.99 | 2023 | Arexvy |
| Biogen, INC. | $109.83 | 2024-2025 | Vumerity, Zurzuvae |
| Merck Sharp & Dohme LLC | $77.78 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $69.67 | 2019-2020 | |
| Agile Therapeutics, INC. | $69.58 | 2021-2024 | Twirla |
| Lupin INC. | $68.47 | 2019-2020 | |
| Evofem Biosciences, INC. | $65.11 | 2021-2025 | Solosec, Phexx, Phexxi |
| Avion Pharmaceuticals | $64.06 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $50.83 | 2023 | Exparel |
| Coopersurgical, INC. | $48.35 | 2019-2022 | |
| Baxter Healthcare | $38.74 | 2025 | Perclot |
| Ethicon US, LLC | $35.38 | 2019-2025 | Stratafix |
| Innovation Technologies INC | $35.18 | 2023 | Irrisept |
| Therapeuticsmd, INC. | $31.39 | 2019-2020 | |
| Davol INC. | $30.37 | 2025 | Arista |
| Ascend Therapeutics US, LLC | $22.31 | 2023 | |
| Vertical Pharmaceuticals, LLC | $20.86 | 2020 | |
| Meditrina | $20.47 | 2023 | |
| Smith+Nephew, INC. | $20.36 | 2019 | |
| Aspira Women'S Health INC | $18.31 | 2022 | |
| Minerva Surgical, INC | $14.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Kindrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.